Skip to main content
Erschienen in: Clinical Neuroradiology 3/2015

01.09.2015 | Original Article

Prognostic Value of Conventional Magnetic Resonance Imaging for Adult Patients with Brain Tumors

verfasst von: L. Klingelhöfer, D. Mucha, K. Geiger, R. Koch, R. von Kummer

Erschienen in: Clinical Neuroradiology | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Magnetic resonance imaging (MRI) is the pivotal diagnostic step in patients with brain tumors, and is performed before histological diagnosis is available. We hypothesized that conventional MRI is as accurate as tumor histology in differentiating malignant from benign clinical course.

Methods

Two neuroradiologists blinded to any clinical information evaluated the first diagnostic MRI of 244 brain tumor patients before any treatment, using a self-developed standardized list of image criteria and prospectively determined world health organization (WHO) tumor grade and tumor entity. All patients were examined with at least T1- and T2-weighted spin echo sequences before and after contrast injection on 1 and 1.5-T MRI scanners. Following the patients prospectively for 8–13 years after diagnosis, we were able to use nonsurvival at 5 years as a criterion for malignity and reference for the prognostic accuracy of both MRI and tumor tissue histology.

Results

The accuracy for predicting nonsurvival at 5 years was 91 % (95 % confidence interval (CI): 87–94 %) for MRI and 92 % (95 % CI: 88–95 %) for histology. The Kaplan–Meier survival curves of patients with benign and malignant brain tumors as diagnosed by MRI or histology differed significantly (p < 0.001). Histology confirmed benignity or malignity in 201 patients (82 %, 95 % CI: 77–87 %). Sources of misdiagnosis were metastases diagnosed as astrocytoma WHO IV, atypical meningiomas, and low-grade astrocytoma with malignant transformation.

Conclusion

MRI appears as accurate as histology in predicting survival at 5 years after diagnosis. Histological diagnosis may be more specific, however, and is needed to assess the tumor’s specific biology.
Literatur
1.
2.
Zurück zum Zitat Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109.PubMedCentralCrossRefPubMed Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114(2):97–109.PubMedCentralCrossRefPubMed
3.
Zurück zum Zitat Westphal M, Lamszus K. The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci. 2011;12(9):495–508.CrossRefPubMed Westphal M, Lamszus K. The neurobiology of gliomas: from cell biology to the development of therapeutic approaches. Nat Rev Neurosci. 2011;12(9):495–508.CrossRefPubMed
4.
Zurück zum Zitat Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46.CrossRef Cohen J. A coefficient of agreement for nominal scales. Educ Psychol Meas. 1960;20:37–46.CrossRef
5.
Zurück zum Zitat Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.CrossRefPubMed Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–74.CrossRefPubMed
6.
Zurück zum Zitat Berry CC. A tutorial on confidence intervals for proportions in diagnostic radiology. AJR Am J Roentgenol. 1990;154(3):477–80.CrossRefPubMed Berry CC. A tutorial on confidence intervals for proportions in diagnostic radiology. AJR Am J Roentgenol. 1990;154(3):477–80.CrossRefPubMed
7.
Zurück zum Zitat Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology (ASCO). J Clin Oncol 1996; 14(2): 671-9. Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. American Society of Clinical Oncology (ASCO). J Clin Oncol 1996; 14(2): 671-9.
8.
Zurück zum Zitat Ocana A, Tannock IF. When are “positive” clinical trials in oncology truly positive? J Natl Cancer Inst. 2011;103(1):16–20.CrossRefPubMed Ocana A, Tannock IF. When are “positive” clinical trials in oncology truly positive? J Natl Cancer Inst. 2011;103(1):16–20.CrossRefPubMed
9.
Zurück zum Zitat McKee AE, Farrell AT, Pazdur R, Woodcock J. The role of the U.S. Food and Drug Administration review process: clinical trial endpoints in oncology. Oncologist. 2010;15(Suppl. 1):13–8. McKee AE, Farrell AT, Pazdur R, Woodcock J. The role of the U.S. Food and Drug Administration review process: clinical trial endpoints in oncology. Oncologist. 2010;15(Suppl. 1):13–8.
10.
Zurück zum Zitat Lutterbach J, Bartelt S, Momm F, Becker G, Frommhold H, Ostertag C. Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1,346 patients with glioblastomas or brain metastases. Cancer. 2005;103(6):1234–44.CrossRefPubMed Lutterbach J, Bartelt S, Momm F, Becker G, Frommhold H, Ostertag C. Is older age associated with a worse prognosis due to different patterns of care? A long-term study of 1,346 patients with glioblastomas or brain metastases. Cancer. 2005;103(6):1234–44.CrossRefPubMed
11.
Zurück zum Zitat Ramnarayan R, Dodd S, Das K, Heidecke V, Rainov NG. Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter. J Neurol Sci. 2007;260(1–2):49–56.CrossRefPubMed Ramnarayan R, Dodd S, Das K, Heidecke V, Rainov NG. Overall survival in patients with malignant glioma may be significantly longer with tumors located in deep grey matter. J Neurol Sci. 2007;260(1–2):49–56.CrossRefPubMed
12.
Zurück zum Zitat McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008;63(4):700–7. Author reply 707–8. McGirt MJ, Chaichana KL, Attenello FJ, Weingart JD, Than K, Burger PC, Olivi A, Brem H, Quinoñes-Hinojosa A. Extent of surgical resection is independently associated with survival in patients with hemispheric infiltrating low-grade gliomas. Neurosurgery. 2008;63(4):700–7. Author reply 707–8.
13.
Zurück zum Zitat Grisold W, Krauseneck P, Müller B. Praktische Neuroonkologie. 1st ed. Wien: Springer-Verlag; 2000. Grisold W, Krauseneck P, Müller B. Praktische Neuroonkologie. 1st ed. Wien: Springer-Verlag; 2000.
14.
Zurück zum Zitat Kaye AH, Laws ER. Brain tumors: an encyclopedic approach. London: Churchhill Livingstone; 2001. Kaye AH, Laws ER. Brain tumors: an encyclopedic approach. London: Churchhill Livingstone; 2001.
15.
Zurück zum Zitat Al-Okaili RN, Krejza J, Woo JH, Wolf RL, O’Rourke DM, Judy KD, Poptani H, Melhem ER. Intraaxial brain masses: MR imaging-based diagnostic strategy—initial experience. Radiology. 2007;243(2):539–50.CrossRefPubMed Al-Okaili RN, Krejza J, Woo JH, Wolf RL, O’Rourke DM, Judy KD, Poptani H, Melhem ER. Intraaxial brain masses: MR imaging-based diagnostic strategy—initial experience. Radiology. 2007;243(2):539–50.CrossRefPubMed
16.
Zurück zum Zitat Arvinda HR, Kesavadas C, Sarma PS, Thomas B, Radhakrishnan VV, Gupta AK, Kapilamoorthy TR, Nair S.  Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol. 2009;94(1):87–96.CrossRefPubMed Arvinda HR, Kesavadas C, Sarma PS, Thomas B, Radhakrishnan VV, Gupta AK, Kapilamoorthy TR, Nair S.  Glioma grading: sensitivity, specificity, positive and negative predictive values of diffusion and perfusion imaging. J Neurooncol. 2009;94(1):87–96.CrossRefPubMed
17.
Zurück zum Zitat Fayed N, Davila J, Medrano J, Olmos S. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Eur J Radiol. 2008;67(3):427–33.CrossRefPubMed Fayed N, Davila J, Medrano J, Olmos S. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Eur J Radiol. 2008;67(3):427–33.CrossRefPubMed
18.
Zurück zum Zitat Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24(10):1989–98.PubMed Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol. 2003;24(10):1989–98.PubMed
19.
Zurück zum Zitat Möller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology. 2002;44(5):371–81.CrossRefPubMed Möller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology. 2002;44(5):371–81.CrossRefPubMed
20.
Zurück zum Zitat Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology. 1992;34(6):463–9.CrossRefPubMed Watanabe M, Tanaka R, Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology. 1992;34(6):463–9.CrossRefPubMed
21.
Zurück zum Zitat Dean BL, Drayer BP, Bird CR, Flom RA, Hodak JA, Coons SW, Carey RG. Gliomas: classification with MR imaging. Radiology. 1990;174(2):411–5.CrossRefPubMed Dean BL, Drayer BP, Bird CR, Flom RA, Hodak JA, Coons SW, Carey RG. Gliomas: classification with MR imaging. Radiology. 1990;174(2):411–5.CrossRefPubMed
22.
Zurück zum Zitat Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg. 1993;79(4):533–6.CrossRefPubMed Kondziolka D, Lunsford LD, Martinez AJ. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg. 1993;79(4):533–6.CrossRefPubMed
23.
Zurück zum Zitat Forsting M, Jansen O. MRT des Zentralnervensystems. Stuttgart: Thieme; 2006. Forsting M, Jansen O. MRT des Zentralnervensystems. Stuttgart: Thieme; 2006.
24.
Zurück zum Zitat Hanft S, Canoll P, Bruce JN. A review of malignant meningiomas: diagnosis, characteristics, and treatment. J Neurooncol. 2010;99(3):433–43.CrossRefPubMed Hanft S, Canoll P, Bruce JN. A review of malignant meningiomas: diagnosis, characteristics, and treatment. J Neurooncol. 2010;99(3):433–43.CrossRefPubMed
25.
Zurück zum Zitat Warmuth-Metz M, Bison B, Leykamm S. Neuroradiologic review in pediatric brain tumor studies. Klin Neuroradiol. 2009;19(4):263–73.CrossRefPubMed Warmuth-Metz M, Bison B, Leykamm S. Neuroradiologic review in pediatric brain tumor studies. Klin Neuroradiol. 2009;19(4):263–73.CrossRefPubMed
26.
Zurück zum Zitat Johannesen TB, Langmark F, Lote K. Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg. 2003;99(5):854–62.CrossRefPubMed Johannesen TB, Langmark F, Lote K. Progress in long-term survival in adult patients with supratentorial low-grade gliomas: a population-based study of 993 patients in whom tumors were diagnosed between 1970 and 1993. J Neurosurg. 2003;99(5):854–62.CrossRefPubMed
27.
Zurück zum Zitat Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schüler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol. 2004;108(1):49–56.CrossRefPubMed Okamoto Y, Di Patre PL, Burkhard C, Horstmann S, Jourde B, Fahey M, Schüler D, Probst-Hensch NM, Yasargil MG, Yonekawa Y, Lütolf UM, Kleihues P, Ohgaki H. Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol. 2004;108(1):49–56.CrossRefPubMed
28.
Zurück zum Zitat Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973–2001. Cancer. 2006;106(6):1358–63.CrossRefPubMed Claus EB, Black PM. Survival rates and patterns of care for patients diagnosed with supratentorial low-grade gliomas: data from the SEER program, 1973–2001. Cancer. 2006;106(6):1358–63.CrossRefPubMed
29.
Zurück zum Zitat Tortosa A, Viñolas N, Villà S, Verger E, Gil JM, Brell M, Caral L, Pujol T, Acebes JJ, Ribalta T, Ferrer I, Graus F. Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer. 2003;97(4):1063–71.CrossRefPubMed Tortosa A, Viñolas N, Villà S, Verger E, Gil JM, Brell M, Caral L, Pujol T, Acebes JJ, Ribalta T, Ferrer I, Graus F. Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer. 2003;97(4):1063–71.CrossRefPubMed
30.
Zurück zum Zitat Shaw EG, Scheithauer BW, O’Fallon JR. Supratentorial gliomas: a comparative study by grade and histologic type. J Neurooncol. 1997;31(3):273–8.CrossRefPubMed Shaw EG, Scheithauer BW, O’Fallon JR. Supratentorial gliomas: a comparative study by grade and histologic type. J Neurooncol. 1997;31(3):273–8.CrossRefPubMed
32.
Zurück zum Zitat Hakyemez B, Yildirim N, Erdogan C, Kocaeli H, Korfali E, Parlak M. Meningiomas with conventional MRI findings resembling intra-axial tumors: can perfusion-weighted MRI be helpful in differentiation? Neuroradiology. 2006;48(10):695–702.CrossRefPubMed Hakyemez B, Yildirim N, Erdogan C, Kocaeli H, Korfali E, Parlak M. Meningiomas with conventional MRI findings resembling intra-axial tumors: can perfusion-weighted MRI be helpful in differentiation? Neuroradiology. 2006;48(10):695–702.CrossRefPubMed
34.
Zurück zum Zitat Shiroishi MS, Habibi M, Rajderkar D, Yurko C, Go JL, Lerner A, Mogensen MA, Kim PE, Boyko OB, Zee CS, Law M. Perfusion and permeability MR imaging of gliomas. Technol Cancer Res Treat. 2011;10(1):59–71.PubMed Shiroishi MS, Habibi M, Rajderkar D, Yurko C, Go JL, Lerner A, Mogensen MA, Kim PE, Boyko OB, Zee CS, Law M. Perfusion and permeability MR imaging of gliomas. Technol Cancer Res Treat. 2011;10(1):59–71.PubMed
35.
Zurück zum Zitat Morita N, Harada M, Otsuka H, Melhem ER, Nishitani H. Clinical application of MR spectroscopy and imaging of brain tumor. Magn Reson Med Sci. 2011;9(4):167–75.CrossRef Morita N, Harada M, Otsuka H, Melhem ER, Nishitani H. Clinical application of MR spectroscopy and imaging of brain tumor. Magn Reson Med Sci. 2011;9(4):167–75.CrossRef
36.
Zurück zum Zitat Gerstner ER, Sorensen AG. Diffusion and diffusion tensor imaging in brain cancer. Semin Radiat Oncol. 2011;21(2):141–6.CrossRefPubMed Gerstner ER, Sorensen AG. Diffusion and diffusion tensor imaging in brain cancer. Semin Radiat Oncol. 2011;21(2):141–6.CrossRefPubMed
37.
Zurück zum Zitat Schneider T, Mawrin C, Scherlach C, Skalej M, Firsching R. Gliomas in adults. Dtsch Arztebl Int. 2011;107(45):799–807. Quiz 808. Schneider T, Mawrin C, Scherlach C, Skalej M, Firsching R. Gliomas in adults. Dtsch Arztebl Int. 2011;107(45):799–807. Quiz 808.
38.
Zurück zum Zitat Tilgner J, Herr M, Ostertag C, Volk B. Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis—influence of clinical factors. Neurosurgery. 2005;56(2):257–65. Discussion 257–65. Tilgner J, Herr M, Ostertag C, Volk B. Validation of intraoperative diagnoses using smear preparations from stereotactic brain biopsies: intraoperative versus final diagnosis—influence of clinical factors. Neurosurgery. 2005;56(2):257–65. Discussion 257–65.
39.
Zurück zum Zitat Muragaki Y, Chernov M, Maruyama T, Ochiai T, Taira T, Kubo O, Nakamura R, Iseki H, Hori T, Takakura K. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate? Minim Invasive Neurosurg. 2008;51(5):275–9.CrossRefPubMed Muragaki Y, Chernov M, Maruyama T, Ochiai T, Taira T, Kubo O, Nakamura R, Iseki H, Hori T, Takakura K. Low-grade glioma on stereotactic biopsy: how often is the diagnosis accurate? Minim Invasive Neurosurg. 2008;51(5):275–9.CrossRefPubMed
40.
41.
Zurück zum Zitat Juratli TA, Kirsch M, Robel K, Soucek S, Geiger K, von Kummer R, Schackert G, Krex D. IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas. J Neurooncol. 2012;108:403–10.CrossRefPubMed Juratli TA, Kirsch M, Robel K, Soucek S, Geiger K, von Kummer R, Schackert G, Krex D. IDH mutations as an early and consistent marker in low-grade astrocytomas WHO grade II and their consecutive secondary high-grade gliomas. J Neurooncol. 2012;108:403–10.CrossRefPubMed
42.
Zurück zum Zitat Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer. 1998;82(9):1749–55.CrossRefPubMed Hall WA. The safety and efficacy of stereotactic biopsy for intracranial lesions. Cancer. 1998;82(9):1749–55.CrossRefPubMed
43.
Zurück zum Zitat Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ. The risk of haemorrhage after image-guided stereotactic biopsy of intra-axial brain tumours—a prospective study. Acta Neurochir (Wien). 2001;143(6):539–45. Discussion 545–6. Kreth FW, Muacevic A, Medele R, Bise K, Meyer T, Reulen HJ. The risk of haemorrhage after image-guided stereotactic biopsy of intra-axial brain tumours—a prospective study. Acta Neurochir (Wien). 2001;143(6):539–45. Discussion 545–6.
44.
Zurück zum Zitat Soo TM, Bernstein M, Provias J, Tasker R, Lozano A, Guha A. Failed stereotactic biopsy in a series of 518 cases. Stereotact Funct Neurosurg. 1995;64(4):183–96.PubMed Soo TM, Bernstein M, Provias J, Tasker R, Lozano A, Guha A. Failed stereotactic biopsy in a series of 518 cases. Stereotact Funct Neurosurg. 1995;64(4):183–96.PubMed
Metadaten
Titel
Prognostic Value of Conventional Magnetic Resonance Imaging for Adult Patients with Brain Tumors
verfasst von
L. Klingelhöfer
D. Mucha
K. Geiger
R. Koch
R. von Kummer
Publikationsdatum
01.09.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology / Ausgabe 3/2015
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-014-0309-3

Weitere Artikel der Ausgabe 3/2015

Clinical Neuroradiology 3/2015 Zur Ausgabe

Editorial

Good News…

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.